Table 3 The prediction of protein annotation pathways of a C. longa miRNAs targets using the STRING tool
ID | KEGG description | Matching proteins in network |
|---|---|---|
hsa01521 | EGFR tyrosine kinase inhibitor resistance | GAB1, EGFR, MET, GRB2 |
hsa04360 | Axon guidance | NTN1, MET, PTPN11, PPP3R2, DCC |
hsa05205 | Proteoglycans in cancer | GAB1, EGFR, MET, PTPN11, GRB2 |
hsa05211 | Renal cell carcinoma | GAB1, MET, PTPN11, GRB2 |
hsa04014 | Ras signalling pathway | GAB1, EGFR, MET, PTPN11, GRB2 |
hsa04072 | Phospholipase D signalling pathway | GAB1, EGFR, PTPN11, GRB2 |
hsa05226 | Gastric cancer | GAB1, EGFR, MET, GRB2 |
hsa05225 | Hepatocellular carcinoma | GAB1, EGFR, MET, GRB2 |
hsa05120 | Epithelial cell signalling in Helicobacter pylori infection | EGFR, MET, PTPN11 |
hsa05223 | Non-small cell lung cancer | EGFR, MET, GRB2 |
hsa04012 | ErbB signalling pathway | GAB1, EGFR, GRB2 |
hsa05210 | Colorectal cancer | EGFR, GRB2, DCC |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | EGFR, PTPN11, PPP3R2 |
hsa05215 | Prostate cancer | EGFR, ETV5, GRB2 |
hsa04722 | Neurotrophin signalling pathway | GAB1, PTPN11, GRB2 |
hsa04650 | Natural killer cell-mediated cytotoxicity | PTPN11, PPP3R2, GRB2 |
hsa04010 | MAPK signalling pathway | EGFR, MET, PPP3R2, GRB2 |
hsa04068 | FoxO signalling pathway | SETD7, EGFR, GRB2 |
hsa04630 | JAK-STAT signalling pathway | EGFR, PTPN11, GRB2 |
hsa05206 | MicroRNAs in cancer | EGFR, MET, GRB2 |
hsa05144 | Malaria | KLRB1, MET |